Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Dimebon in Patients With Mile-to-Moderate Huntington Disease
Conditions
Interventions
Dimebon
Placebo
Locations
37
United States
Scottsdale, Arizona, United States
Davis, California, United States
Irvine, California, United States
La Jolla, California, United States
San Francisco, California, United States
Gainsville, Florida, United States
Start Date
July 1, 2009
Primary Completion Date
July 1, 2011
Last Updated
October 12, 2016
NCT04012411
NCT06414967
NCT05822908
NCT03434548
NCT06444217
NCT05686551
Lead Sponsor
Medivation, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions